Private Equity Intelligence
Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.
SK Capital Partners
A global private investment firm invested across leading companies in the specialty materials, ingredients, and life sciences sectors.
- Class
- Buyout firmconfirmed, confidence 85%
- Basis
- R6: 35 of 35 distinct vehicles are sworn Private Equity Funds; 31 reported gross assets on a filing in 2022 or later
- Size band
- Upper middle marketdefined by: proxy: $7.98bn Private Equity Fund GAV on the Form ADV filed 2024-03-26
Classification history (1)
- Sep 13, 2026Buyout firm (confirmed, 85%, cls-pe-1)R6: 35 of 35 distinct vehicles are sworn Private Equity Funds; 31 reported gross assets on a filing in 2022 or later
- Adviser type
- registered investment adviser
- Form ADV filings
- Feb 15, 2012 to Mar 26, 2024
- RAUM
- $8.0Bregulatory assets under management of the adviser; not dry powder, not a fund size
- PE funds, latest filing
- 32
- PE fund GAV, latest filing
- $8.0Breported gross assets (Form ADV), not fund size
- All private fund GAV
- $8.0Bevery private fund type, latest filing
- 2024 PE fund GAV
- $8.0Bsum over funds typed Private Equity Fund with a 2024 or later as-of date
- PE share of funds, lifetime
- 100%
- Fund type mix
- filed 2024-03-26, latest gav Private Equity Fund $8.0B, latest counts Private Equity Fund 32, lifetime distinct Private Equity Fund 35
- Employees
- 73
- Headquarters
- New York, NY
- Office address
- 430 PARK AVENUE, 18TH FLOOR, New York, NY, 10022
- Business phone
- 212-826-2700
- Sectors
- technology, life sciences, aerospace defense
- Geography
- not stated or not yet read
- Revenue
- not stated or not yet read
- EBITDA
- not stated or not yet read
- Enterprise value
- not stated or not yet read
- Equity check
- not stated or not yet read
- Control
- control
- Thesis
- We bring this disciplined focus to every investment we make, which has resulted in a reputation for being a preferred partner for management, owners, and sellers of businesses.
- roles
- add on 9, unknown 47, platform 10
- period
- to 2026-09-10, from 2009-01-01, undated holdings 9, dated observations 69
- window
- last 2026-09-10, first 2016-01-05
- control
- control 12, unknown 54
- companies
- 64
- geography
- count 1, share 0.016, value NJ, count 1, share 0.016, value FL, count 1, share 0.016, value MI
- investments
- 66
- seller kinds
- transactions
- 12
- cadence by year
- 2016 add ons 1, 2019 add ons 1, 2022 add ons 2, platforms 1, 2023 add ons 1, platforms 1, 2024 add ons 1, 2025 add ons 1, platforms 1, 2026 add ons 2
- platform add on
- add ons 9, platforms 10, add ons per platform 0.9
- sector known for
- 45
- disclosed value usd
- n 0
- sector distribution
- count 27, share 0.422, value industrial manufacturing, examples TechmerPM, Isolatek International, Florachem Holdings, LLC, Valtris, count 8, share 0.125, value life sciences, examples Spectrum Vascular, Halo Pharmaceutical, Precera Medical, Swixx BioPharma, count 4, share 0.062, value industrial services, examples Calabrian Corporation, Milestone Environmental Services, Perimeter Solutions, Smiley Facility, count 3, share 0.047, value specialty distribution, examples Brothers International, Tilley, Spectra Confectionery Limited, count 2, share 0.031, value aerospace defense, examples Milestone, Axillon Aerospace, count 1, share 0.016, value agriculture, examples Extractas Bioscience
- holding period years
- n 1, median 3.3
- repeat counterparties
- subsector distribution
- count 9, share 0.141, value plastics rubber products, examples TechmerPM, Valtris, Portage Plastics Assets, SI Group, count 8, share 0.125, value miscellaneous manufacturing, examples Lacerta, Heubach, Additive Metal Services, Foremark Performance Chemicals, count 6, share 0.094, value life sciences, examples Halo Pharmaceutical, Precera Medical, Swixx BioPharma, Genetix Biotherapeutics, count 6, share 0.094, value chemical manufacturing, examples Valtris Specialty Chemicals, Tri-Tex, Archroma, Deltech LLC, count 2, share 0.031, value medical devices, examples Spectrum Vascular, Piccolo Medical, count 2, share 0.031, value aerospace defense, examples Milestone, Axillon Aerospace, count 2, share 0.031, value waste treatment, examples Calabrian Corporation, Smiley Facility, count 1, share 0.016, value agriculture, examples Extractas Bioscience
64 companies on the graph (12 transactions); most in industrial manufacturing (27); 10 platforms and 9 add-ons; median observed hold 3.3 years (n=1); observed 2009 to 2026
| Fund | Vehicle | Vintage | Reported gross assets (Form ADV), not fund size | GAV by year | Form D sold | Lifecycle |
|---|---|---|---|---|---|---|
| Skcp VI Artemis Co-Invest, L.P. ADV: Private Equity Fund | Co-investment vehicle | 2024 first reported on Form ADV | $642M as of Mar 26, 2024 | no Form D | Unknown | |
| Skcp IV Adinah Co-Invest, L.P. ADV: Private Equity Fund | Co-investment vehicle | 2024 first reported on Form ADV | $12.9M as of Mar 26, 2024 | no Form D | Unknown | |
| Skcp Catalyst Fund Ii-A LP ADV: Private Equity Fund | Feeder or parallel | 2023 first reported on Form ADV | $127M as of Mar 26, 2024 | no Form D | Unknown | |
| Skcp Catalyst Fund Ii-B LP ADV: Private Equity Fund | Feeder or parallel | 2023 first reported on Form ADV | $48.1M as of Mar 26, 2024 | no Form D | Unknown | |
| SK Capital Partners Vi-A, L.P. ADV: Private Equity Fund | Buyout fund | 2022 first reported on Form ADV | $1.5B as of Mar 26, 2024 | no Form D | Early deployment | |
| SK Capital Partners Vi-B, L.P. ADV: Private Equity Fund | Buyout fund | 2022 first reported on Form ADV | $627M as of Mar 26, 2024 | no Form D | Early deployment | |
| Skcp V Sirona Co-Invest, L.P. ADV: Private Equity Fund | Co-investment vehicle | 2022 first reported on Form ADV | $187M as of Mar 26, 2024 | no Form D | Early deployment | |
| Skcp Catalyst Fund I-A, LP ADV: Private Equity Fund | Feeder or parallel | 2020 first reported on Form ADV | $316M as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp Catalyst Fund I-B, LP ADV: Private Equity Fund | Feeder or parallel | 2020 first reported on Form ADV | $101M as of Mar 26, 2024 | no Form D | Harvest | |
| SK Capital Partners V-A, L.P. ADV: Private Equity Fund | Buyout fund | 2019 first reported on Form ADV | $1.7B as of Mar 26, 2024 | no Form D | Unknown | |
| SK Capital Partners V-B, L.P. ADV: Private Equity Fund | Buyout fund | 2019 first reported on Form ADV | $696M as of Mar 26, 2024 | no Form D | Mature | |
| SK Capital Partners Overage Fund V-A, LP ADV: Private Equity Fund | Buyout fund | 2019 first reported on Form ADV | $83.1M as of Mar 26, 2024 | no Form D | Mature | |
| Skcp Mohawk Co-Invest LP ADV: Private Equity Fund | Co-investment vehicle | 2019 first reported on Form ADV | $32.3M as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp Mohawk PE Co-Invest LP ADV: Private Equity Fund | Co-investment vehicle | 2019 first reported on Form ADV | $0 as of Mar 31, 2023 | no Form D | Wound down | |
| Skcp IV Boost Co-Invest, L.P. ADV: Private Equity Fund | Co-investment vehicle | 2018 first reported on Form ADV | $39.8M as of Mar 26, 2024 | no Form D | Unknown | |
| Skcp IV Invictus Co-Invest, L.P. ADV: Private Equity Fund | Co-investment vehicle | 2018 first reported on Form ADV | $0 as of Mar 31, 2023 | no Form D | Wound down | |
| Skcp IV Groundhog Co-Invest L.P. ADV: Private Equity Fund | Co-investment vehicle | 2017 first reported on Form ADV | $102M as of Mar 26, 2024 | no Form D | Unknown | |
| Skcp III Groundhog Aiv, L.P. ADV: Private Equity Fund | Feeder or parallel | 2017 first reported on Form ADV | $43.2M as of Mar 26, 2024 | no Form D | Unknown | |
| Skcp II Groundhog Aiv, L.P. ADV: Private Equity Fund | Feeder or parallel | 2017 first reported on Form ADV | $0 as of Mar 26, 2024 | no Form D | Harvest | |
| SK Capital Partners II, L.P. ADV: Private Equity Fund | Buyout fund | 2016 first reported on Form ADV | $96.4M as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp II Spice Aiv, L.P. ADV: Private Equity Fund | Feeder or parallel | 2016 first reported on Form ADV | $14.3M as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp II Blue Aiv, L.P. ADV: Private Equity Fund | Feeder or parallel | 2016 first reported on Form ADV | $13.3M as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp III Dionysus Aiv, L.P. ADV: Private Equity Fund | Feeder or parallel | 2016 first reported on Form ADV | $193,250 as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp II Dionysus Aiv, L.P. ADV: Private Equity Fund | Feeder or parallel | 2016 first reported on Form ADV | $123,125 as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp II Angel Aiv, L.P. ADV: Private Equity Fund | Feeder or parallel | 2016 first reported on Form ADV | $34,749 as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp III Spice Co-Invest Aiv, L.P. ADV: Private Equity Fund | Co-investment vehicle | 2015 first reported on Form ADV | $114M as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp III Angel Aiv, LP ADV: Private Equity Fund | Feeder or parallel | 2015 first reported on Form ADV | $31,553 as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp III Glades Co-Invest Aiv, L.P. ADV: Private Equity Fund | Co-investment vehicle | 2015 first reported on Form ADV | $11,579 as of Mar 26, 2024 | no Form D | Unknown | |
| SK Capital Partners Iv-A, L.P. ADV: Private Equity Fund | Buyout fund | 2014 first reported on Form ADV | $987M as of Mar 26, 2024 | no Form D | Unknown | |
| SK Capital Partners Iv-B, L.P. ADV: Private Equity Fund | Buyout fund | 2014 first reported on Form ADV | $219M as of Mar 26, 2024 | no Form D | Unknown | |
| Skcp III Spice Aiv, LP ADV: Private Equity Fund | Feeder or parallel | 2014 first reported on Form ADV | $124M as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp III Blue Aiv, LP ADV: Private Equity Fund | Feeder or parallel | 2014 first reported on Form ADV | $117M as of Mar 26, 2024 | no Form D | Harvest | |
| Skcp III Rose Aiv, LP ADV: Private Equity Fund | Feeder or parallel | 2013 first reported on Form ADV | $4.0M as of Feb 14, 2019 | no Form D | Wound down | |
| Sckp III Glades Aiv, LP ADV: Private Equity Fund | Feeder or parallel | 2013 first reported on Form ADV | $29,186 as of Mar 26, 2024 | no Form D | Mature | |
| SK Capital Partners III, L.P. ADV: Private Equity Fund | Buyout fund | unknown | $704,822 as of Mar 26, 2024 | no Form D | Harvest |
- Aaron Charles Davenport · Partner · since Jul 1, 2011 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- Barry B Siadat · Member · since Apr 1, 2016 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- Jamshid Mark Keynejad · Member · since Apr 1, 2016 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- John Anthony Norris · Partner · since Jul 1, 2011 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- John Anthony Norris · a Managing Director · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- John Anthony Norris · a Managing Director · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- Jon Borell · Managing Director · start date unknown Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)
- James Victor Gaven · Chief Compliance Officer/General Counsel · since May 1, 2022 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- Jerome Truzzolino · Chief Financial Officer · since Jan 1, 2015 SEC Form ADV filing data 2011 to 2024 (Schedule D 7.B.(1) private funds, Schedules A/B, 1.I websites)
- Choose Category · Executive Committee · start date unknown Investment organization websites (team, portfolio, strategy, criteria, news)
5 former (kept with end dates)
- James P Marden · Partner · Jul 1, 2011 to Mar 30, 2020 Inference
- Andrew James Jenkinson · Chief Compliance Officer · Jun 1, 2018 to Mar 31, 2021 Inference
- Carolyn Grace Fischer · Chief Financial Officer · May 1, 2010 to Mar 30, 2015 Inference
- Jennifer Murphy Cattier · Chief Compliance Officer / General Counsel · Jun 1, 2021 to May 11, 2022 Inference
- Mark N Delevie · Chief Compliance Officer · Jan 1, 2012 to Mar 30, 2015 Inference
- UBS Securities LLC 6 shared · very strong · last Jan 1, 2019
- Partners Group (USA) Inc. 1 shared · one time · last Nov 3, 2025
- Cerberus Business Finance 1 shared · one time · last Oct 4, 2023
- Five Arrows 1 shared · one time · last Nov 3, 2025
- Houlihan Lokey 1 shared · one time · last Oct 4, 2023
- White & Case 1 shared · one time · last Oct 4, 2023
- Sachs & Company 1 shared · one time · last Oct 4, 2023
- Sycomore Corporate Finance 1 shared · one time · last Nov 3, 2025
- White & Case 1 shared · one time · last Oct 4, 2023
- Dentons 1 shared · one time · last Nov 3, 2025
- Latham & Watkins LLP 1 shared · one time · last Oct 4, 2023
- Kirkland & Ellis LLP 1 shared · one time · last Nov 3, 2025
- Sachs & Company 1 shared · one time · last Oct 4, 2023
- Teachers' Retirement System of the State of Illinois amount not disclosed trsil.org
- Los Angeles City Employees' Retirement System in SK Capital Partners Vi-A, L.P. amount not disclosed lacers.org
- Los Angeles City Employees' Retirement System in SK Capital Partners Vi-A, L.P. $40.0M lacers.org
- Sep 10, 2026Jon Borell Appointed as Member of SK Capital Executive Committee
- Jul 1, 2026Apotex Completes Previously Announced Strategic Transaction with Cumberland Pharmaceuticals
- Jun 11, 2026Spectrum Vascular Acquires Piccolo Medical, Accelerating Launch of Next-Generation Catheter Navigation Technology
- Apr 21, 2026Catchment Capital Announces Definitive Agreement to Acquire Isolatek International
- Apr 2, 2026SK Capital Partners: Private Equity Funds on Form ADV 32 (2024 extract) -> 28 (roster 2026-09-01)
- Nov 3, 2025SK Capital Completes Acquisition of LISI Group’s Medical Division and Launches New Platform as Precera Medical
- Jun 2, 2025Teachers' Retirement System of the State of Illinois reports SK Capital Partners: an undisclosed amount committedLp commitment disclosedFactTeachers' Retirement System of the State of IllinoisPublic pension private-markets disclosures, read through the venture lane's LP report tape
- Oct 4, 2023SK Capital Acquires Milestone Environmental Services
- Feb 15, 2012SK Capital Partners first filed Form ADV in the extract (IA)
SK Capital Partners is the same institution as 3 records in Independent Sponsors, RIA and Wealth and Allocators.
Which record it is in each graph, what it is called there, and what the two were joined on. The Data Factory holds all nine graphs and the identity layer between them.
Checking your plan…